Challenges and Potential Solutions for Recruitment and Retention of Hematopoietic Cell Transplant Physicians: the National Marrow Donor Program's System Capacity Initiative Physician Workforce Group Report.

Publication Type:

Journal Article


Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation (2014)


2014, Clinical Research Division, March 2014


Hematopoietic cell transplantation (HCT) remains the only known curative therapy for many patients with hematologic, metabolic and immunologic disorders. Furthermore, the use of HCT has increased with the emergence of HCT as a viable therapeutic option for older patients, those with significant co-morbidities, and, with the demonstrated clinical effectiveness of alternative allogeneic donor sources, for those patients without a suitable sibling donor. The National Marrow Donor ProgramĀ® (NMDP) estimates that by 2020 it will facilitate 10,000 transplants per year, double the number in 2010. To understand the HCT infrastructure needs to facilitate this number of transplants, the NMDP organized the System Capacity Initiative 2020, centered on 6 working groups representing a diverse group of stakeholders. The Physician Workforce Group was tasked with addressing issues relating to recruitment and retention of transplant physicians. We report here the results of our efforts and future initiatives.